Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study
Open Access
- 31 January 2011
- journal article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 10 (1), 54-62
- https://doi.org/10.1016/s1474-4422(10)70269-6
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Bivalent phenethylamines as novel dopamine transporter inhibitors: evidence for multiple substrate‐binding sites in a single transporterJournal of Neurochemistry, 2010
- Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystoniaJCI Insight, 2009
- Infantile parkinsonism-dystonia: a dopamine “transportopathy”JCI Insight, 2009
- Clinical and genetic delineation of neurodegeneration with brain iron accumulationJournal of Medical Genetics, 2008
- Dopamine spillover after quantal release: Rethinking dopamine transmission in the nigrostriatal pathwayBrain Research Reviews, 2008
- Mitochondrial diseases mimicking neurotransmitter defectsMitochondrion, 2008
- The Role of N-Glycosylation in Function and Surface Trafficking of the Human Dopamine TransporterJournal of Biological Chemistry, 2004
- Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystoniaAnnals of Neurology, 2003
- A Paradigm Shift in Brain ResearchScience, 2001
- Cerebrospinal Fluid Investigations for Neurometabolic DisordersNeuropediatrics, 1998